BioMarin Pharmaceutical | BMRN - Capitale Sociale E Riserve

Prezzo Delle Azioni
54.35
Cambio Giornaliero
0.14 0.26%
Mensile
-3.79%
Annuale
-13.33%
Q2 Previsione
52.04




Capitale Sociale E Riserve Cambiamento Data
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amgen USD 8.66B 961M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
Incyte USD 5.62B 455.37M 2026-03
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Moderna USD 8.65B 680M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 71.71B 14.25B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 7.1B 506M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12